Citations

Clear

6 citation(s) found for "Wieringa, Bé".

Does the duration of ambulatory consultations affect the quality of healthcare? A systematic review
León‐García, Montserrat , Wieringa, Thomas H. , Hernández, María José , Villanueva, Gemma , Ospina, Naykky Singh , Hidalgo, Jessica, Calderón, Claudio Rocha, Zeballos‐Palacios, Claudia , Brito, Juan P. , Zeballos-Palacios, Claudia, Brito, Juan Pablo, Singh Ospina, Naykky , Brito, Juan P , Suárez, Nataly R. Espinoza , Prokop, Larry J. , LeBlanc, Annie , Montori, Víctor M.

Mayo Clinic

BMJ Open Quality | October 24, 2023 | Volume: 12 | Issue: 4 | Pages: e002311

10.1136/bmjoq-2023-002311 | PMID 37875307 Get It

Background The objective is to examine and synthesise the best available experimental evidence about the effect of ambulatory consultation duration on quality of healthcare. Methods We included experimental studies manipulating the length of outpatient clinical encounters between adult patients and clinicians (ie, therapists, pharmacists, nurses, physicians) to determine their effect on quality of care (ie, effectiveness, efficiency, timeliness, safety, equity, patient-centredness and patient satisfaction). Information sources Using controlled vocabulary and keywords, without restriction by language or year of publication, we searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews and Scopus from inception until 15 May 2023. Risk of bias Cochrane Risk of Bias instrument. Data synthesis Narrative synthesis. Results 11 publications of 10 studies explored the relationship between encounter duration and quality. Most took place in the UK’s general practice over two decades ago. Study findings based on very sparse and outdated evidence—which suggested that longer consultations improved indicators of patient-centred care, education about prevention and clinical referrals; and that consultation duration was inconsistently related to patient satisfaction and clinical outcomes—warrant low confidence due to limited protections against bias and indirect applicability to current practice. Conclusion Experimental evidence for a minimal or optimal duration of an outpatient consultation is sparse and outdated. To develop evidence-based policies and practices about encounter length, randomised trials of different consultation lengths—in person and virtually, and with electronic health records—are needed. Trial registration number OSF Registration DOI:10.17605/OSF.IO/EUDK8.
Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs
Whitfield, Kyly C. , Adamolekun, Bola, Bergeron, Gilles, Brown, Kenneth H. , Cox, Lorna, Fattal‐Valevski, Aviva , Frank, Elizabeth L., Hiffler, Laurent , Hlaing, Lwin Mar , Kapner, Hallie, Mousavi, Maral P. S. , Roth, Daniel , Tsaloglou, Maria‐Nefeli , Wieringa, Frank T. , Combs, Gerald F., Fischer, Philip R. , Bourassa, Megan W. , Bettendorff, Lucien , Jefferds, Maria Elena , Kounnavong, Sengchanh

Mayo Clinic

Annals of the New York Academy of Sciences | August 28, 2018 | Volume: 1430 | Issue: 1 | Pages: 3-43

10.1111/nyas.13919 | PMID 30151974 Get It

AbstractThiamine is an essential micronutrient that plays a key role in energy metabolism. Many populations worldwide may be at risk of clinical or subclinical thiamine deficiencies, due to famine, reliance on staple crops with low thiamine content, or food preparation practices, such as milling grains and washing milled rice. Clinical manifestations of thiamine deficiency are variable; this, along with the lack of a readily accessible and widely agreed upon biomarker of thiamine status, complicates efforts to diagnose thiamine deficiency and assess its global prevalence. Strategies to identify regions at risk of thiamine deficiency through proxy measures, such as analysis of food balance sheet data and month‐specific infant mortality rates, may be valuable for understanding the scope of thiamine deficiency. Urgent public health responses are warranted in high‐risk regions, considering the contribution of thiamine deficiency to infant mortality and research suggesting that even subclinical thiamine deficiency in childhood may have lifelong neurodevelopmental consequences. Food fortification and maternal and/or infant thiamine supplementation have proven effective in raising thiamine status and reducing the incidence of infantile beriberi in regions where thiamine deficiency is prevalent, but trial data are limited. Efforts to determine culturally and environmentally appropriate food vehicles for thiamine fortification are ongoing.
Absence of myofibrillar creatine kinase and diaphragm isometric function during repetitive activation
Labella, John J., Daood, Monica J., Koretsky, Alan P. , Roman, Brian B. , Wieringa, Bé , Sieck, Gary C. , Watchko, Jon F.

Mayo Clinic

Journal of Applied Physiology | December 22, 2017 | Volume: 84 | Issue: 4 | Pages: 1166-1173

10.1152/jappl.1998.84.4.1166 | PMID 9516180 Get It

Creatine kinase (CK) provides ATP buffering in skeletal muscle and is expressed as 1) cytosolic myofibrillar CK (M-CK) and 2) sarcomeric mitochondrial CK (ScCKmit) isoforms that differ in their subcellular localization. We compared the isometric contractile and fatigue properties of 1) control CK-sufficient (Ctl), 2) M-CK-deficient (M-CK[−/−]), and 3) combined M-CK/ScCKmit-deficient null mutant (CK[−/−]) diaphragm (Dia) to determine the effect of the absence of M-CK activity on Dia performance in vitro. Baseline contractile properties were comparable across groups except for specific force, which was ∼16% lower in CK[−/−] Dia compared with M-CK[−/−] and Ctl Dia. During repetitive activation (40 Hz, [Formula: see text] duty cycle), force declined in all three groups. This decline was significantly greater in CK[−/−] Dia compared with Ctl and M-CK[−/−] Dia. The pattern of force decline did not differ between M-CK[−/−] and Ctl Dia. We conclude that Dia isometric muscle function is not absolutely dependent on the presence of M-CK, whereas the complete absence of CK acutely impairs isometric force generation during repetitive activation.
Combined myofibrillar and mitochondrial creatine kinase deficiency impairs mouse diaphragm isotonic function
Daood, Monica J., Labella, John J., Ameredes, Bill T., Koretsky, Alan P. , Wieringa, Bé , Watchko, Jon F. , Sieck, Gary C.

Mayo Clinic

Journal of Applied Physiology | December 22, 2017 | Volume: 82 | Issue: 5 | Pages: 1416-1423

10.1152/jappl.1997.82.5.1416 | PMID 9134887 Get It

Watchko, Jon F., Monica J. Daood, Gary C. Sieck, John J. LaBella, Bill T. Ameredes, Alan P. Koretsky, and Be Wieringa. Combined myofibrillar and mitochondrial creatine kinase deficiency impairs mouse diaphragm isotonic function. J. Appl. Physiol. 82(5): 1416–1423, 1997.—Creatine kinase (CK) is an enzyme central to cellular high-energy phosphate metabolism in muscle. To characterize the physiological role of CK in respiratory muscle during dynamic contractions, we compared the force-velocity relationships, power, and work output characteristics of the diaphragm (Dia) from mice with combined myofibrillar and sarcomeric mitochondrial CK deficiency (CK[−/−]) with CK-sufficient controls (Ctl). Maximum velocity of shortening was significantly lower in CK[−/−] Dia (14.1 ± 0.9 Lo/s, where Lois optimal fiber length) compared with Ctl Dia (17.5 ± 1.1 Lo/s) ( P < 0.01). Maximum power was obtained at 0.4–0.5 tetanic force in both groups; absolute maximum power (2,293 ± 138 W/m2) and work (201 ± 9 J/m2) were lower in CK[−/−] Dia compared with Ctl Dia (2,744 ± 146 W/m2and 284 ± 26 J/m2, respectively) ( P < 0.05). The ability of CK[−/−] Dia to sustain shortening during repetitive isotonic activation (75 Hz, 330-ms duration repeated each second at 0.4 tetanic force load) was markedly impaired, with CK[−/−] Dia power and work declining to zero by 37 ± 4 s, compared with 61 ± 5 s in Ctl Dia. We conclude that combined myofibrillar and sarcomeric mitochondrial CK deficiency profoundly impairs Dia power and work output, underscoring the functional importance of CK during dynamic contractions in skeletal muscle.
Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion
Pucar, Darko , Bast, Peter, Gumina, Richard J. , Lim, Lynette , DRAHL, CARMEN, Juranić, Nenad, Janssen, Edwin, Wieringa, Bé , Dzeja, Petras P. , Macura, Slobodan , Terzic, André

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | March 3, 2015 | Volume: 283 | Issue: 2 | Pages: H776-H782

10.1152/ajpheart.00116.2002 | PMID 12124227 Get It

Deletion of the major adenylate kinase AK1 isoform, which catalyzes adenine nucleotide exchange, disrupts cellular energetic economy and compromises metabolic signal transduction. However, the consequences of deleting the AK1 gene on cardiac energetic dynamics and performance in the setting of ischemia-reperfusion have not been determined. Here, at the onset of ischemia, AK1 knockout mice hearts displayed accelerated loss of contractile force compared with wild-type controls, indicating reduced tolerance to ischemic stress. On reperfusion, AK1 knockout hearts demonstrated reduced nucleotide salvage, resulting in lower ATP, GTP, ADP, and GDP levels and an altered metabolic steady state associated with diminished ATP-to-Piand creatine phosphate-to-Piratios. Postischemic AK1 knockout hearts maintained ∼40% of β-phosphoryl turnover, suggesting increased phosphotransfer flux through remaining adenylate kinase isoforms. This was associated with sustained creatine kinase flux and elevated cellular glucose-6-phosphate levels as the cellular energetic system adapted to deletion of AK1. Such metabolic rearrangements, along with sustained ATP-to-ADP ratio and total ATP turnover rate, maintained postischemic contractile recovery of AK1 knockout hearts at wild-type levels. Thus deletion of the AK1 gene reveals that adenylate kinase phosphotransfer supports myocardial function on initiation of ischemic stress and safeguards intracellular nucleotide pools in postischemic recovery.
Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels
Carrasco, Antonio J., Dzeja, Petras P. , Alekseev, Alexey E., Pucar, Darko , Zingman, Leonid V. , Abraham, M. Roselle , Hodgson, Denice M., Bienengraeber, Martin, Pucéat, Michel , Janssen, Edwin, Wieringa, Bé , Carrasco, Antonio J., Terzic, André

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 98 | Issue: 13 | Pages: 7623-7628

10.1073/pnas.121038198 | PMID 11390963 Get It

Transduction of energetic signals into membrane electrical events governs vital cellular functions, ranging from hormone secretion and cytoprotection to appetite control and hair growth. Central to the regulation of such diverse cellular processes are the metabolism sensing ATP-sensitive K + (K ATP ) channels. However, the mechanism that communicates metabolic signals and integrates cellular energetics with K ATP channel-dependent membrane excitability remains elusive. Here, we identify that the response of K ATP channels to metabolic challenge is regulated by adenylate kinase phosphotransfer. Adenylate kinase associates with the K ATP channel complex, anchoring cellular phosphotransfer networks and facilitating delivery of mitochondrial signals to the membrane environment. Deletion of the adenylate kinase gene compromised nucleotide exchange at the channel site and impeded communication between mitochondria and K ATP channels, rendering cellular metabolic sensing defective. Assigning a signal processing role to adenylate kinase identifies a phosphorelay mechanism essential for efficient coupling of cellular energetics with K ATP channels and associated functions.